DPHARMA

1.190

(%)

Changes in Sub. S-hldr's Int (Section 138 of CA 2016)

DUOPHARMA BIOTECH BERHAD

Particulars of substantial Securities Holder

Name EMPLOYEES PROVIDENT FUND BOARD
Address TINGKAT 19, BANGUNAN KWSP, JALAN RAJA LAUT
KUALA LUMPUR
50350 Wilayah Persekutuan
Malaysia.
Company No. EPF ACT 1991
Nationality/Country of incorporation Malaysia
Descriptions (Class) Ordinary Shares

Details of changes

No Date of change
No of securities
Type of Transaction Nature of Interest
11 Feb 2020
23,600
Acquired Direct Interest
Name of registered holder Citigroup Nominees (Tempatan) Sdn. Bhd.
Address of registered holder Level 42, Menara Citibank, 165 Jalan Ampang, 50450 Kuala Lumpur.
Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred Acquisition of 23,600 shares by Citigroup Nominees (Tempatan) Sdn. Bhd. - Employees Provident Fund Board
Nature of interest Indirect Interest
Direct (units)
Direct (%)
Indirect/deemed interest (units) 47,900,157
Indirect/deemed interest (%) 6.999
Total no of securities after change 47,900,157
Date of notice 12 Feb 2020
Date notice received by Listed Issuer 14 Feb 2020


Remarks :
Total number of Duopharma Biotech Berhad (formerly known as CCM Duopharma Biotech Berhad) shares held are as follows:-

(a) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD : 23,522,058

(b) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD (AM INV) : 4,696,278

(c) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD (CIMB PRI) : 13,676,431

(d) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD (ASIANISLAMIC) IC : 3,727,790

(e) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD (RHBISLAMIC) IC : 2,277,600

(f) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD (ABERISLAMIC) IC : 0


Announcement Info

Company Name DUOPHARMA BIOTECH BERHAD
Stock Name DPHARMA
Date Announced 14 Feb 2020
Category Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016
Reference Number CS2-14022020-00040